Literature DB >> 12390339

Serum leptin and CD4+ T lymphocytes in HIV+ children during highly active antiretroviral therapy.

G Matarese1, G Castelli-Gattinara, C Cancrini, S Bernardi, M L Romiti, C Savarese, A Di Giacomo, P Rossi, L Racioppi.   

Abstract

OBJECTIVE: Because leptin, the adipocyte-derived hormone, affects thymocyte survival, proliferation of naïve T lymphocytes and the production of proinflammatory cytokines, we aimed to investigate the role of this molecule in immunoreconstitution during highly active antiretroviral therapy (HAART).
DESIGN: Prospective longitudinal cohort study. A series of 20 HIV+ children were studied. The subjects were grouped by their increase in serum leptin levels after HAART.
METHODS: All participants were weight-stable, free of endocrine disorders and opportunistic infections and equally distributed for sex (males, n=10; females, n=10). Body mass index (BMI), serum lipids, leptin, CD4+ T cells and HIV-1 RNA were measured before initiation of HAART and after a 2-year follow-up.
RESULTS: Serum leptin concentration positively correlated with CD4+ lymphocyte number before treatment. HAART significantly reduced viraemia and increased serum levels of lipids in all patients, whereas a significant increase in CD4+ cells and serum leptin was observed in the majority of patients. Notably, in children where HAART was not effective in increasing CD4+ lymphocyte counts, serum leptin did not increase.
CONCLUSION: To our knowledge, these findings reveal for the first time a novel link among CD4+ T lymphocytes, serum leptin and highly active anteretroviral theraphy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12390339     DOI: 10.1046/j.1365-2265.2002.01634.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  7 in total

Review 1.  The Head-to-Toe Hormone: Leptin as an Extensive Modulator of Physiologic Systems.

Authors:  Monica Misch; Prasanth Puthanveetil
Journal:  Int J Mol Sci       Date:  2022-05-13       Impact factor: 6.208

2.  Selective capacity of metreleptin administration to reconstitute CD4+ T-cell number in females with acquired hypoleptinemia.

Authors:  Giuseppe Matarese; Claudia La Rocca; Hyun-Seuk Moon; Joo Young Huh; Mary T Brinkoetter; Sharon Chou; Francesco Perna; Dario Greco; Holly P Kilim; Chuanyun Gao; Kalliope Arampatzi; Zhaoxi Wang; Christos S Mantzoros
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

3.  Serum adipokines and HIV viral replication in patients undergoing antiretroviral therapy.

Authors:  Victoria Aramă; Cătălin Tilişcan; Daniela Adriana Ion; Raluca Mihăilescu; Daniela Munteanu; Anca Streinu-Cercel; Ana Maria Tudor; Adriana Hristea; Viorica Leoveanu; Ioana Olaru; Stefan Sorin Aramă
Journal:  Germs       Date:  2012-03-01

Review 4.  Unraveling the multiple roles of leptin in inflammation and autoimmunity.

Authors:  Antonio La Cava; Carlo Alviggi; Giuseppe Matarese
Journal:  J Mol Med (Berl)       Date:  2003-10-10       Impact factor: 4.599

5.  Leptin stimulates the oxidative burst in control monocytes but attenuates the oxidative burst in monocytes from HIV-infected patients.

Authors:  C Sánchez-Pozo; J Rodriguez-Baño; A Domínguez-Castellano; M A Muniain; R Goberna; V Sánchez-Margalet
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

Review 6.  Emergence of Leptin in Infection and Immunity: Scope and Challenges in Vaccines Formulation.

Authors:  Dayakar Alti; Chandrasekaran Sambamurthy; Suresh K Kalangi
Journal:  Front Cell Infect Microbiol       Date:  2018-05-09       Impact factor: 5.293

Review 7.  Susceptibility and Severity of Viral Infections in Obesity: Lessons from Influenza to COVID-19. Does Leptin Play a Role?

Authors:  Valeria Guglielmi; Luca Colangeli; Monica D'Adamo; Paolo Sbraccia
Journal:  Int J Mol Sci       Date:  2021-03-20       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.